-
AKR1C pan-inhibitor overcomes drug resistance in breast cancer models
24 Apr 2025 22:26 GMT
… doxorubicin significantly reduces its therapeutic efficacy, limiting its clinical use in breast cancer …
-
ROS-Responsive Biomimetic Nanocomplexes of Liposomes and Macrophage-Derived Exosomes for Combination Breast Cancer Therapy
23 Apr 2025 15:59 GMT
… therapeutic efficacy against breast cancer.
Abbreviations
MPS, … enhanced triple-negative breast cancer treatment through … dihydroartemisinin effectively treat breast cancer by enhancing … effective doxorubicin delivery to treat breast cancer and melanoma …
-
Keeping Up With The Growing Number of Treatments for Breast Cancer
22 Apr 2025 18:19 GMT
… of early detection.³,⁵
Breast cancer treatment is highly … effects. For example, doxorubicin is associated with cardiotoxicity … patients receiving trastuzumab.
Breast cancer remains a critical … positioned to support breast cancer patients through our …
-
My 11-Year Metastatic Breast Cancer Story Defied the Standard Path
21 Apr 2025 20:31 GMT
… , I was diagnosed with metastatic breast cancer. I had a lump that … of the “red devil” chemo, Adriamycin (doxorubicin), and Cytoxan (cyclophosphamide) and was … majority of patients with metastatic breast cancer. Even after my mastectomy, I …
-
Nanoparticle-Based Strategies to Enhance the Efficacy of STING Activators in Cancer Immunotherapy
26 Apr 2025 05:08 GMT
… BRCA1-deficient triple-negative breast cancer and ERCC1-deficient … melanoma and triple-negative breast cancer.17 Collectively, these … progression in melanoma and breast cancer models.152 Furthermore, … double-stranded DNA and doxorubicin, which accumulate in …
-
Current Status of Breast Cancer Immunotherapy and Prognosis-Related Markers
15 Apr 2025 06:45 GMT
… docetaxel, and doxorubicin across various malignancies … including lung adenocarcinomas, breast cancers, hepatocellular carcinomas, … Trends in Breast Cancer Immunotherapy
Breast cancer immunotherapy has … infiltration in breast cancer. Clin Breast Cancer. 2023; …
-
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
02 Apr 2025 16:42 GMT
… paclitaxel-carboplatin and doxorubicin/epirubicin- … negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022 … triple-negative breast cancer (TNBC). Clin Breast Cancer. 2024; … in triple negative breast cancer. Breast Cancer Res.;19(1): …
-
Black cumin seed oil emerges as a powerful ally against breast cancer and chronic inflammation
29 Mar 2025 01:33 GMT
… —particularly in combating breast cancer and taming the … reversing drug resistance in doxorubicin- and tamoxifen-resistant … reduces radiation dermatitis in breast cancer patients, proving its … immune responses.
With breast cancer rates climbing and conventional …
-
UP scientists aim to improve breast cancer treatment with compound found in sea
25 Mar 2025 07:27 GMT
An all-female research group from the University of the Philippines found that a compound derived from Philippine blue sponge could provide a synergistic effect when combined with cancer drug doxorubicin in treating advanced or metastatic breast cancer.
-
The Safety and Efficacy of Anticancer Therapy in Breast Cancer Patients with Liver Cirrhosis
19 Mar 2025 11:08 GMT
… docetaxel) based therapy, anthracycline (doxorubicin) + taxane (docetaxel) based … metastasis.
Abbreviations
BC, breast cancer; LC, liver cirrhosis; … and BRCA2-associated breast cancer. Breast Cancer Res Treat. 2016 … therapy for breast cancer patients with …